BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 16874690)

  • 1. Staphylococcal protein A immunoadsorption for Goodpasture's syndrome in four Chinese patients.
    Hu W; Liu Z; Ji D; Xie H; Gong D; Li L
    J Nephrol; 2006; 19(3):312-7. PubMed ID: 16874690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case report of efficiency of double filtration plasmapheresis in treatment of Goodpasture's syndrome.
    Hajime N; Michiko A; Atsunori K; Tatsuo K; Yuko N; Naoki O; Katsuhiko S
    Ther Apher Dial; 2009 Aug; 13(4):373-7. PubMed ID: 19695077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapeutic immunoadsorption in Goodpasture disease].
    Moreso F; Poveda R; Gil-Vernet S; Carreras L; García-Osuna R; Griñó JM; Alsina J
    Med Clin (Barc); 1995 Jun; 105(2):59-61. PubMed ID: 7603097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specificity of kidney-bound antibodies in Goodpasture's syndrome.
    Saxena R; Bygren P; Butkowski R; Wieslander J
    Clin Exp Immunol; 1989 Oct; 78(1):31-6. PubMed ID: 2805421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Double filtration plasmapheresis in case of Goodpasture's syndrome].
    Kumazaki S; Umeda Y; Sato K; Mishima H; Ishihara T; Uzawa T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Apr; 28(4):628-33. PubMed ID: 2214405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cadaveric renal transplantation for Goodpasture's syndrome: a case report].
    Miyazato M; Koyama Y; Miyazato T; Yonou H; Naito A; Sugaya K; Hatano T; Ogawa Y
    Hinyokika Kiyo; 2001 Jul; 47(7):493-5. PubMed ID: 11523135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of Goodpasture's syndrome with massive pulmonary hemorrhage ameliorated by cyclophosphamide pulse therapy].
    Uezu Y; Kiyatake I; Tokuyama K
    Nihon Jinzo Gakkai Shi; 1999 Aug; 41(5):499-504. PubMed ID: 10502944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcome of patients with coexistent antineutrophil cytoplasmic antibodies and antibodies against glomerular basement membrane.
    Lindic J; Vizjak A; Ferluga D; Kovac D; Ales A; Kveder R; Ponikvar R; Bren A
    Ther Apher Dial; 2009 Aug; 13(4):278-81. PubMed ID: 19695059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical spectrum of acute glomerulonephritis and lung haemorrhage (Goodpasture's syndrome).
    Holdsworth S; Boyce N; Thomson NM; Atkins RC
    Q J Med; 1985 Apr; 55(216):75-86. PubMed ID: 4011844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Course and prognosis of anti-basement membrane antibody (anti-BM-Ab)-mediated disease: report of 35 cases.
    Merkel F; Pullig O; Marx M; Netzer KO; Weber M
    Nephrol Dial Transplant; 1994; 9(4):372-6. PubMed ID: 8084449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Failure of plasma exchange and immunosuppression to improve renal function in Goodpasture's syndrome.
    McLeish KR; Maxwell DR; Luft FC
    Clin Nephrol; 1978 Aug; 10(2):71-3. PubMed ID: 699402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and morphological aspects of the management of crescentic anti-glomerular basement membrane antibody (anti-GBM) nephritis/Goodpasture's syndrome.
    Walker RG; Scheinkestel C; Becker GJ; Owen JE; Dowling JP; Kincaid-Smith P
    Q J Med; 1985 Jan; 54(213):75-89. PubMed ID: 3975346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of anti-basement membrane (BM) mediated disease presenting renal and pulmonary symptoms by divergent timing].
    Usutani S; Nosaka H; Shirai M; Akimoto H; Kojima K; Shimomura M; Kakuta S; Nagase M; Sado Y
    Nihon Jinzo Gakkai Shi; 1997 Jul; 39(5):512-6. PubMed ID: 9283218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transplantation, immunosuppression and plasmapheresis in Goodpasture's syndrome.
    Cove-Smith JR; McLeod AA; Blamey RW; Knapp MS; Reeves WG; Wilson CB
    Clin Nephrol; 1978 Mar; 9(3):126-8. PubMed ID: 346273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A patient with Goodpasture's syndrome revealed a poor prognosis regardless of receiving intensive therapy from an early stage after onset].
    Hidaka S; Kaneda K; Shite S; Ohkuma K; Yoshimatsu H; Horita M; Miyazaki E; Takebayashi S; Sakata T
    Nihon Jinzo Gakkai Shi; 1996 Feb; 38(2):103-8. PubMed ID: 8717313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Goodpasture's syndrome--effects of plasmapheresis.
    Munk ZM; Skamene E
    Clin Exp Immunol; 1979 May; 36(2):244-9. PubMed ID: 477027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics and outcomes of patients with Goodpasture's syndrome.
    Shah MK; Hugghins SY
    South Med J; 2002 Dec; 95(12):1411-8. PubMed ID: 12597309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of anti-GBM-antibody positive rapidly progressive glomerulonephritis who was weaned from hemodialysis after combination therapy with steroid and plasmapheresis].
    Kitaura K; Asano K
    Nihon Jinzo Gakkai Shi; 2005; 47(8):887-92. PubMed ID: 16408434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and features of dual anti-GBM-positive and ANCA-positive patients.
    DE Zoysa J; Taylor D; Thein H; Yehia M
    Nephrology (Carlton); 2011 Nov; 16(8):725-9. PubMed ID: 21649794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of patients with lipoprotein glomerulopathy by protein A immunoadsorption: a pilot study.
    Xin Z; Zhihong L; Shijun L; Jinfeng Z; Huiping C; Caihong Z; Daxi J; Leishi L
    Nephrol Dial Transplant; 2009 Mar; 24(3):864-9. PubMed ID: 18840890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.